Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
about
MRI reveals differential effects of amphetamine exposure on neuroglia in vivoCurrent approaches to enhance CNS delivery of drugs across the brain barriersBarrier mechanisms in the brain, I. Adult brain.Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.Vector-mediated drug delivery to the brain.Peptide nucleic acid (PNA) binding-mediated gene regulation.Drug transport to brain with targeted nanoparticles.Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.Peptide nucleic acids: versatile tools for gene therapy strategies.Recent advances in the development of peptide nucleic acid as a gene-targeted drug.Antisense imaging of gene expression in the brain in vivoDNA and RNA derivatives to optimize distribution and deliveryBrain drug delivery of small molecules using immunoliposomesTargeted delivery across the blood-brain barrier.Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.CNS drug delivery: opioid peptides and the blood-brain barrierNoninvasive tracking of gene transcript and neuroprotection after gene therapy.shRNA and siRNA delivery to the brainDrug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptorImmunoliposomes doubly targeted to transferrin receptor and to α-synuclein.Strategies for enhanced drug delivery to the central nervous system.Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs.Shuttle-mediated drug delivery to the brain.The use of convection-enhanced delivery with liposomal toxins in neurooncology.Liposomes for brain delivery.CNS drug targeting: have we travelled in right path?Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Transbuccal Delivery of CNS Therapeutic Nanoparticles: Synthesis, Characterization, and In Vitro Permeation Studies.Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase.Characterization of transferrin receptor in an immortalized cell line of rat brain endothelial cells, RBE4.A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review.PNAs breach the blood-brain barrier?Production and characterization of fusion proteins containing transferrin and nerve growth factor.Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells.Cloning and expression in Pichia pastoris of a genetically engineered single chain antibody against the rat transferrin receptor.Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.Drug transport across the blood-brain barrier
P2860
Q22065963-6CA35FAC-391D-4BAE-949C-9B722C01F99BQ30437835-EBC48016-C563-447C-92E8-C6F97AEED8BAQ33535015-456B9C15-8854-41E1-8382-FE20FF99BCFDQ33622573-6E86CDF7-967F-40DE-AF9C-5EB665D7D3F0Q33827984-00F6832C-96B6-4919-BA22-EC9E9DE2F832Q33956192-EAA21FED-FDE0-41E1-AE3D-980D7A6ADEF4Q33977872-8DE883A9-FF62-4246-BD0D-FBFBDFECF4B5Q33985140-858EFD57-81D3-4B0B-8B50-EB08AF01444FQ33996836-993744B0-9E94-44C8-8392-B15F89B17E19Q34079542-DAC6651D-EC06-4781-B085-0EEF9B2BAE58Q35684860-2AA6C359-1BC8-4420-B0E2-5EF14F8385B3Q35853732-D569211C-A314-4FC4-A70F-F71A3BBAD1D6Q35858691-EAE5700F-6B09-4F1A-A2BC-8AD56AE5114FQ35947016-1628F9F4-5203-437D-9F04-27A77B7C8BE5Q36316725-ED593CA3-C25B-4CD6-A6F5-4D72C2D09FEFQ36390910-EF2AF885-74CD-4328-A29A-A39A5C849D70Q36439195-A086D72F-F893-4D80-8424-14A5A3881A5DQ36445653-DDCA56BF-5302-419B-A5AA-D2D7761CE4F4Q36791813-16D44BDF-DDCD-4257-AB15-39C5AC643DA5Q37372948-F0289C59-7F46-4441-9CAF-48F483E0E315Q37474296-57FB0BC4-11AC-4E88-9553-A168A74AB1B8Q37666694-1BC1500A-6EFA-42D2-A0A5-1B4BF8BDC7D0Q37834512-0CA14E44-1A67-4AB4-B078-AAE35EA15FA8Q37896550-6CC68512-86B8-44BE-8C8D-36C5CB4F7D5EQ37954331-0793F087-B418-4AEF-B5AA-E3040A9E883AQ38078421-E3736351-6D0F-4073-84FE-B0458A91A4C4Q38127262-BBEA6773-F986-48FC-A575-21F44D11EE3BQ38265614-D3DAE19E-B7A7-40BC-9A71-D7DC23334710Q38339934-F57A9607-F568-482C-B3E8-335CFDF13249Q38401892-A987CF20-DF1B-426C-BD89-2C417FA63C82Q39878016-220F6574-438B-44C9-972D-69FE4F0BBA1FQ40947859-17650147-66A5-482D-9562-FD58E09A29DFQ40968203-2505C556-A7FD-436D-92CD-DE9EAFBA0A7EQ42458889-9CCD81C5-274F-4FD0-8D97-0E2EF010D067Q48147484-231D48EC-27E3-4EEE-A2CF-228F157E8894Q48377810-E7896C3F-BCED-424F-BBF7-CAD7D4842FCBQ48895733-623583F3-C135-4C35-A274-5A3033917CF7Q48895749-EFE812E2-E569-4A7A-8D7E-5D9E5022C385Q48895801-D3111CEA-F3E0-4F6F-B869-96FA0888D2EFQ57677287-ECD4CDD3-95CA-4E25-AE27-1808C57316E3
P2860
Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@ast
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@en
Vector-mediated delivery of a polyamide
@nl
type
label
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@ast
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@en
Vector-mediated delivery of a polyamide
@nl
prefLabel
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@ast
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@en
Vector-mediated delivery of a polyamide
@nl
P2860
P356
P1476
Vector-mediated delivery of a ...... e blood-brain barrier in vivo.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.12.5592
P407
P577
1995-06-01T00:00:00Z